ArticleInsights into imaging2024

Correction: The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis.

Lanqing Cong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.